View in EDS HTML Full Text PDF Full Text

Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients.

Saved in:
Bibliographic Details
Title: Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients.
Authors: Su, Tung ‐ Hung1,2, Hu, Tsung ‐ Hui3, Chen, Chi ‐ Yi4, Huang, Yi ‐ Hsiang5,6, Chuang, Wan ‐ Long7, Lin, Chun ‐ Che8, Wang, Chia ‐ Chi9, Su, Wei ‐ Wen10, Chen, Ming ‐ Yao11, Peng, Cheng ‐ Yuan12, Chien, Rong ‐ Nan13, Huang, Yi ‐ Wen14, Wang, Horng ‐ Yuan15, Lin, Chih ‐ Lin16, Yang, Sheng ‐ Shun17, Chen, Tsung ‐ Ming18, Mo, Lein ‐ Ray19, Hsu, Shih ‐ Jer20, Tseng, Kuo ‐ Chih21, Hsieh, Tsai ‐ Yuan22
Source: Liver International. Dec2016, Vol. 36 Issue 12, p1755-1764. 10p. 6 Charts, 2 Graphs.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14783223
DOI:10.1111/liv.13253